Financhill
Back

Sinopharm Group Stock Predictions

Sinopharm Group Stock Forecast

  • Is Sinopharm Group Stock Undervalued?
    The current Sinopharm Group [SHTDF] share price is $2.55. The Score for SHTDF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SHTDF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sinopharm Group Stock Go Up Next Year?

Data Unavailable

Sinopharm Group Stock Rating

Data Unavailable

Sinopharm Group Stock Price History

Is SHTDF stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SHTDF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
China
Industry:
Health Care Providers & Services
Sector:
Health Care
Type:
stock
Website:
sinopharmgroup.com.cn

52-Week Data

52-Week High:
2.95
52-Week Low:
1.97

Prediction Charts

Market Cap:
7.96B
Price in USD:
2.55
Volume:
0
Beta:
0.59

Technical Analysis

SMA50:
2.38
SMA100:
2.31
SMA200:
2.51
52-Wk Change:
6.36%

Stock Predictions

  • Is Sinopharm Group stock public?
    Yes, Sinopharm Group is a publicly traded company.
  • What is the Sinopharm Group stock quote today?
    The Sinopharm Group stock price is 2.55 USD today.
  • How to buy Sinopharm Group stock online?
    You can buy Sinopharm Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 2.52 2.52 2.52 2.52
Nov-26 2.52 2.52 2.52 2.52
Nov-27 2.52 2.52 2.52 2.52
Nov-29 2.52 2.52 2.52 2.52
Dec-2 2.52 2.52 2.52 2.52
Dec-3 2.52 2.52 2.52 2.52
Dec-4 2.52 2.52 2.52 2.52
Dec-5 2.52 2.52 2.52 2.52
Dec-6 2.52 2.52 2.52 2.52
Dec-9 2.52 2.52 2.52 2.52
Dec-10 2.52 2.52 2.52 2.52
Dec-11 2.55 2.55 2.55 2.55
Dec-12 2.55 2.55 2.55 2.55
Dec-13 2.55 2.55 2.55 2.55

Sinopharm Group Earnings

Data Unavailable

Sinopharm Group Forecast Revenue Growth

Data Unavailable

* Sinopharm Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.